Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Osteoblastoma

ClinicalTrials.gov lists 1 trial for Osteoblastoma or a narrower condition beneath it.

MeSH D018215 Neoplasms Neoplasm C04 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 3 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 3 Rare-disease identity Rare-disease identity 2

Rows recorded per section

4 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Osteoblastoma itself; the rest are tagged with a narrower condition beneath it.

Get the Osteoblastoma report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Osteoblastoma trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2018 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Osteoblastoma trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 2 1

How many Osteoblastoma trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Osteoblastoma? (3)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Four-week remotely supervised aerobic exercise during the COVID-19 era: Exploring physical performance and psychosocial health in adults without COVID-19 living in rural settings. Medicine 2025 Yes
Percutaneous cryoablation of osteoblastoma in the proximal femur. Skeletal radiology 2020 Yes
Reconstruction with pasteurized autograft for primary malignant bone tumor of distal tibia. Bulletin du cancer 2012 Yes

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Osteoblastoma 58040 Exact Orphadata Science knowledge files, Product 1
Osteoblastoma 58040 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages